Novo Holdings, Glenview Capital and b2venture led the Series E round, which will fund commercial expansion in the US.
"Our commitment to delivering innovative solutions for acute care has never been stronger. This financing round provides the resources to solidify Quanta as the best-in-class solution across the care continuum, to significantly expand our commercial operations, while continuing to introduce enhancements that will strengthen our long-term competitive position."
The Bath-based sustainable ingredients developer secured backing from Eos Advisory, Progress Tech Transfer, CDP Venture Capital, and Paragon Capital Management.
"Giovanna and her team are tackling one of the most urgent environmental challenges of our time, and we look forward to supporting Naturbeads through its next, exciting phase of commercialisation."
The seed round was co-led by PT1 and LEA Partners to support team expansion and product development.
"In my previous experience working in architecture practices, the process of getting images and animations made could cost anywhere from a few hundred to £10,000 and take up to two weeks."
The oversubscribed round was led by Venrex with participation from 8VC, Form Ventures, and several venture scout funds.
"With the adoption of AI in creative tools, the amount of creative work is now growing by 30% a year. For example, last year, more photographs were generated than have ever been taken by human photographers. So, we’ve been asking ourselves ‘what infrastructure is going to be needed to manage this volume of work?’. One problem that doesn’t scale well is issue checking – there’s no Grammarly for creative work and to date this tedious work is still done by eye. Beyond issue checking, we believe AI provides creatives with insights akin to accessing a panel of experts. We see the role of AI as enabling people’s creative processes, not replacing them"